US Growth Equity Basket II

About the Asset

Clearwater Ventures II is a diversified basket of 12–18 late-stage private US growth companies across SaaS, fintech, and healthcare technology. The fund provides accredited investors with institutional access to pre-IPO equity at series C and D valuations, managed by a team with $3.2B in prior venture and growth equity deployments.

Investment Thesis

Public market IPO windows remain selective, creating an extended window to acquire late-stage private equity at compelling valuations. Our pipeline includes companies with $50M–$500M ARR, strong unit economics, and clear paths to liquidity via IPO or strategic acquisition within the fund's 4-year horizon.

Key Highlights

• Diversified basket of 12–18 late-stage US growth companies
• Average portfolio company ARR: $85M with 35% YoY growth
• Access to institutional-grade deal flow at Series C/D valuations
• Target liquidity via IPO or M&A within 4-year fund horizon
• Quarterly NAV reports with independent portfolio company valuations
• Co-investment rights on select deals for investors above $500K

Documents

Available to verified accredited investors after access request.